Abstract
Sixty percent of all intracranial neoplasms are of glial origin. As a result of their infiltrative growth and heterogeneity, standard treatment (surgery, chemotherapy, and radiotherapy) is noncurative (2,2). Patient survival is poor and has not significantly improved over the past 20 years. It is a common belief in the neuro-oncology field that development of combination therapies for malignant brain tumors will be essential if improvement in survival is to occur (3,4). To test experimental single and multimodal therapies, animal and in vitro models of brain tumors are necessary.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cavanee, W. K., Bigner, D. D., Newcomb, E. W., Paulus, W., and Kleihues, P. (1997) Diffuse astrocytomas. In: Kleihues, P. and Cavenee, W. K. (eds.) Pathology and Genetics of Tumours of the Nervous System, International Agency for Research on Cancer, Lyon, France, pp. 2ā9.
Laws, E. R., Jr. (1998) Central nervous system tumors: what have we learned and where are we heading? Ca Cancer J. Clin. 48, 327ā329.
Paul, D. B. and Kruse, C. A. (2001) Immunologic approaches to therapy for brain tumors. Curr. Neurol. Neurosci. Rep. 1, 238ā244.
Virasch, N. and Kruse, C. A. (2001) Strategies using the immune system for therapy of brain tumors. In: Liang, B. C. (ed.) Hematology/Oncology Clinics of North America, Vol. 15, Saunders, Philadelphia, PA, pp. 1053ā1071,.
Bigner, D. D., Bigner, S. H., Ponten, J., et al. (1981) Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40, 201ā229.
Bakir, A., Gezen, F., Yildiz, O., et al. (1998) Establishment and characterization of a human glioblastoma multiforme cell line. Cancer Genet. Cytogenet 103, 46ā51.
Helseth, E., Dalen, A., Unsgaard, G., Vik, R., and Helseth, A. (1989) Overexpression of the epidermal growth factor receptor gene in a human carcinoma cell line derived from a brain metastasis. J. Neuro-oncol. 7, 81ā88.
Joy, A., Panicker, S., and Shapiro J. R. (2000) Altered nuclear localization of bax protein in BCNU-resistant glioma cells. J. Neuro-oncol. 49, 117ā129.
Silbergeld, D. L., and Chicoine, M. R. (1997) Isolation and characterization of human malignant glioma cells from histologically normal brain. J. Neurosurg. 86, 525ā531.
Kruse, C. A., Mitchell, D. H., Kleinschmidt-DeMasters, B. K., et al. (1992) Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression and tumor suppressor gene analysis. In Vitro Cell. Dev. Biol. 28A, 609ā614.
Kruse, C. A., Varella-Garcia, M., Kleinschmidt-DeMasters, B. K., et al. (1998) Receptor expression, cytogenetic, and molecular analysis of six continuous human glioma cell lines. In Vitro Cell. Dev. Biol. 34, 455ā462.
Westphal, M. and Meissner, H. (1998) Establishing human glioma-derived cell lines. Methods in Cell Biol. 57, 147ā165.
Oakes, W., Friedman, H. S., Bigner, S. H., Bullock, N. H., and Bigner, D. D. (1990) Successful laboratory growth and analysis of CUSA-obtained medulloblastoma samples, J. Neurosurg. 72, 821ā823.
Gjerset, R. A., Fakhrai, H., Shawler, D. L., et al. (1995) Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway. In Vitro Cell. Dev. Biol. Animal 31, 207ā214.
Dropcho, E. J. (2001) Novel chemotherapeutic approaches to brain tumors. In: Liang, B. C. (ed), Hematology/Oncology Clinics of North America, Vol. 15, Saunders, Philadelphia, PA, pp. 1027ā1052.
Fuller, C. and Perry, A. (2002) Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol. 12, 67ā86.
Meyer-Puttlitz, B., Hayashi, Y., Waha, A., et al. (1997) Molecular genetic analysis of giant cell glioblastomas. Am. J. Pathol. 151, 853ā857.
Shapiro, J. R. (2001) Genetics of nervous system tumors. In: Liang, B. C. (ed.) Hematology/Oncology Clinics of North America, Vol. 16, Saunders, Philadelphia, PA, pp. 961ā977.
Rempel, S. A. (2001) Molecular biology of nervous system tumors. In: Liang, B. C. (ed.) Hematology/Oncology Clinics of North America, Vol. 15, Saunders, Philadelphia, PA, pp. 979ā1006.
Malden, L. T., Novak, U., Kaye, A. H., and Burgess, A. W. (1988) Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res. 48, 2711ā2714.
von Deimling, A., Louis, D. N., von Ammon, K., et al. (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme, J. Neurosurg. 77, 295ā301.
Fults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A., and Cathon, R. M. (1992) p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res. 52, 674ā679.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Gomez, G.G., Kruse, C.A. (2004). Isolation and Culture of Human Brain Tumor Cells. In: Langdon, S.P. (eds) Cancer Cell Culture. Methods in Molecular Medicineā¢, vol 88. Humana Press. https://doi.org/10.1385/1-59259-406-9:101
Download citation
DOI: https://doi.org/10.1385/1-59259-406-9:101
Publisher Name: Humana Press
Print ISBN: 978-1-58829-079-3
Online ISBN: 978-1-59259-406-1
eBook Packages: Springer Protocols